New York, May 10, 2025 — DR. SMILE MEDICAL GROUP, INC., a fast-growing medical service organization dedicated to the management of venous disease, has officially obtained its Health Maintenance Organization (HMO) classification under the U.S. National Provider Identifier (NPI) registry. This milestone marks the group’s formal integration into the U.S. healthcare network and paves the way for the launch of its flagship New York CHIVA Center, a specialized clinic for varicose vein management based on the CHIVA methodology.
The National Provider Identifier (NPI), issued by the Centers for Medicare & Medicaid Services (CMS), is a 10-digit number that identifies healthcare providers and organizations within the U.S. system. The HMO classification is particularly significant for DR. SMILE MEDICAL GROUP, enabling it to operate as a compliant and coordinated Medical Service Organization (MSO), capable of managing clinical operations, care coordination, and insurance billing across state lines.
DR. SMILE MEDICAL GROUP specializes in minimally invasive, hemodynamics-based vein care, and is internationally recognized for its work in promoting CHIVA (Conservative Hemodynamic Cure for Venous Insufficiency) as a modern, patient-friendly approach to varicose vein treatment. With the acquisition of the HMO-type NPI, the organization will now be able to standardize operations across its expanding global network of CHIVA Centers, targeting markets across North America, Asia, and Africa.
As part of the New York CHIVA Center’s development, the NPI framework will allow seamless integration between clinical teams, IT systems, and administrative workflows. This positions the center as a model of operational excellence and patient-centered care.
Strategic Benefits of the HMO NPI Implementation:
- Interstate Scalability: Enables compliant billing, referrals, and data sharing across U.S. states.
- Operational Integration: Supports centralized procurement, talent management, and clinical data analytics.
- Brand Cohesion: Ensures a unified patient experience and clinical standard across all CHIVA Centers.
“Our mission is to make world-class vein care both accessible and efficient,” said a company representative. “This new designation strengthens our ability to coordinate globally while delivering localized care that meets the highest international standards.”
With the U.S. operations now underway, DR. SMILE MEDICAL GROUP is set to accelerate its global expansion. Following the New York launch, new CHIVA Centers are planned for Los Angeles and other major metropolitan areas, further establishing the group as a leader in minimally invasive vein treatment worldwide.